GlaxoSmithKline Takes $400 Million Legal Charge

GlaxoSmithKline PLC said it will take a $400 million charge in the fourth quarter for legal costs related to an investigation by U.S. authorities into the pharmaceutical company’s marketing and promotion practices.
International Herald Tribune